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Abstract
Background: Flagellar secretion systems are utilized by a wide variety of bacteria to construct the flagellum, a
conserved apparatus that allows for migration towards non-hostile, nutrient rich environments. Chlamydia
pneumoniae is an obligate, intracellular pathogen whose genome contains at least three orthologs of flagellar
proteins, namely FliI, FlhA and FliF, but the role of these proteins remains unknown.
Results: Full length FliI, and fragments of FlhA, FliF, and FliI, were cloned and expressed as either GST or His
tagged proteins in E. coli. The GST-tagged full length FliI protein was shown to possess ATPase activity, hydrolyzing
ATP at a rate of 0.15 ± .02 μmol min
-1 mg
-1 in a time- and dose-dependant manner. Using bacterial-2-hybrid and
GST pull-down assays, the N-terminal domain of FliI was shown to interact with the cytoplasmic domain of FlhA,
but not with FliF, and the cytoplasmic domain of FlhA was shown to interact with the C-terminus of FliF. The
absence of other flagellar orthologs led us to explore cross-reaction of flagellar proteins with type III secretion
proteins, and we found that FliI interacted with CdsL and CopN, while FlhA interacted with CdsL and Cpn0322
(YscU ortholog CdsU).
Conclusions: The specific interaction of the four orthologous flagellar proteins in C. pneumoniae suggests that they
interact in vivo and, taken together with their conservation across members of the chlamydiae sps., and their
interaction with T3S components, suggests a role in bacterial replication and/or intracellular survival.
Background
Chlamydia pneumoniae is a gram negative, obligate
intracellular pathogen that has been associated with
community-acquired pneumonia [1], atherosclerosis [2],
arthritis [3], and Alzheimer’s disease [4]. C. pneumoniae
is characterized by a unique, biphasic life cycle begin-
ning with an infectious, metabolically attenuated ele-
mentary body (EB). Chlamydial invasion is initiated by
attachment of the EB to the host eukaryotic cell mem-
brane and recruitment of actin to the site of attachment.
This remodeling of the actin cytoskeleton is thought to
be mediated by the type III secretion (T3S) effector pro-
tein, the translocated actin recruitment protein (TARP),
which facilitates chlamydial entry into the host cell [5,6].
Bacterial uptake involves modulation of the host MEK-
ERK pathway and PI 3-kinase, possibly through the
action of T3S effectors [7,8]. Once internalized, the
remainder of the chlamydial life cycle takes place within
a parasitophorous membrane-bound vesicle known as
an inclusion, where EBs differentiate into the non-infec-
tious, metabolically active form, termed a reticulate
body (RB). Within the inclusion, RBs acquire amino
acids, nucleotides, lipids and cholesterol from the host
cell, events possibly orchestrated via T3S across the
inclusion membrane, while at the same time inhibiting
apoptosis to ensure survival [9-11]. Golgi fragmentation
appears to be a crucial step in intercepting host path-
ways to obtain these nutrients and compounds, as well
as in the maturation of the chlamydiae sps. within the
inclusion [12]. The RB interacts with the inclusion
membrane until such time as inclusion membrane RB
docking sites are no longer available and an unknown
signal triggers detachment of the RB from the inclusion
membrane followed by asynchronous differentiation into
EBs [13,14]. The newly formed EBs then exit the cell by
either cellular lysis or a packaged release mechanism
termed extrusion [15].
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t e r e dt h r o u g h o u tt h eg e n o m ei ns e v e r a lf r a g m e n t e d
operons. The T3S injectisome has a high amount of
paralogy to the flagellar secretion system in structure
and in function. In the T3SS, CdsN is the ATPase that
aids in shuttling effectors through the needle, and is
paralogous to FliI [16]. CdsL is orthologous to YscL and
paralogous to FliH. In Yersinia, YscL is the ATPase
tethering protein and functions to down-regulate enzy-
matic activity of YscN [17]. CopN, orthologous to
YopN, is believed to function as a regulator of the sys-
tem which plugs the injectisome pore prior to activation
of T3S and is a known effector protein [18]. CdsU,
orthologous to YscU, plays an important role is sub-
strate specificity and substrate switching from structural
components to effector proteins upon host cell contact
[19]. Recently, several reports have emerged characteriz-
ing protein interactions within the C. pneumoniae T3SS,
d e s c r i b i n gn o v e lp r o t e i nc o m p l e x e st h a tf o r ma tt h e
inner membrane. Johnson et al have shown that CdsD, a
unique protein orthologous to YscD that contains two
fork-head associated domains, interacts with the pre-
dicted C. pneumoniae ATPase tethering protein, CdsL,
and CdsQ, a cytosolic component of the inner mem-
brane that presumably forms the bulk of the T3S C-ring
[20]. Stone et al extended these findings to show that
CdsN, the ATPase, is also involved in this complex as
well as interacting with the proposed plug protein,
CopN [16].
Flagellar motility is an ancient, conserved mechanism
that may have evolved from the same ancestor as T3S
[21]. This motility facilitates bacterial migration towards
less hostile environments. In non-motile bacteria, how-
ever, the presence of flagella would be evolutionarily
redundant and energetically expensive, unless the pro-
teins played a role in another mechanism involving bac-
terial replication or survival. Although C. pneumoniae is
thought to be a non-motile bacteria, it has been shown
to contain at least three orthologs of flagellar genes,
namely flhA, fliF, and fliI [22,23]. Microarray and pro-
teomic experiments have suggested that these genes are
expressed at mid-cycle [23]. The proteins encoded by
these genes are paralogs of the T3S proteins CdsV, CdsJ
and CdsN, respectively. In motile bacteria, FlhA ortho-
logs are integral membrane proteins required for flagel-
lin export and swarming differentiation which interact
with soluble components of the flagellar system [24,25].
FliF orthologs are integral membrane components that
form the membrane and supramembrane (MS) ring
[26]. FliF forms a base for the other membrane compo-
nents to form a molecular pore, through which compo-
nents of the flagella that exist outside the cell
membrane are exported. The flagellar ATPase, FliI
orthologs, provide energy for construction of the
flagellum by aiding in export of flagellar proteins outside
the bacterial cell where the proteins form molecular
complexes [27,28]. The presence of FliI, FlhA and FliF
in C. pneumoniae is not sufficient to form a fully func-
tional flagellar apparatus but they could potentially form
a rudimentary base for a flagellum structure [29]. In
chlamydiae, the identity of other proteins (if they exist)
that play important roles in the flagellar apparatus is
currently pending, but it is possible that the flagellar
apparatus, if it exists, is a hybrid structure of C. pneu-
moniae T3S and flagellar proteins. Another possibility is
that flagellar proteins are involved in T3S, aiding in
secretion of effector proteins or structural components.
In Pseudomonas, there is evidence to support that flagel-
lar assembly actually antagonizes the T3SS, suggesting a
negative cross-regulation of the two systems [30]. No
interaction between chlamydial T3S and flagellar com-
ponents, however, has been reported to our knowledge.
The protein interactions that occur within the bacter-
ial flagellar system have been characterized previously
[29,31,32]. Genetic evidence, followed by direct bio-
chemical assays, suggests an interaction of FlhA and FliF
[33,34]. The C-terminal end of FlhA, which is predicted
to be cytoplasmic, is known to interact with the soluble
components of the flagellar system such as FliI, FliH
and FliJ [34,35]. FliH acts as a negative regulator of the
flagellar ATPase, FliI, and binds FliI as a homodimer,
forming a trimeric (FliI)(FliH)2 complex [36-38]. FliJ, a
second soluble component which interacts with FlhA,
acts as a general chaperone for the flagellar system to
prevent premature aggregation of export substrates in
the cytoplasm, and also interacts with the FliH/FliI com-
plex [39]. This complex of FliI/FliH/FliJ is believed to be
crucial for selection of export substrates and construc-
tion of the flagellar apparatus, although the proton
motive force could play a role in the actual secretion of
flagellar proteins [28,40]. In C. pneumoniae,F l i Ha n d
FliJ have not been annotated in the genome.
FliI, the putative C. pneumoniae flagellar ATPase
ortholog, has significant amino acid similarity with both
CdsN, the C. pneumoniae T3S ATPase, and FliI, the
Salmonella flagellar ATPase, suggesting that it possesses
enzymatic activity. Here we report an initial characteri-
zation of FliI, the flagellar ATPase, and show that it
hydrolyzes ATP at a rate similar to that of its T3S
ATPase paralog CdsN as well as orthologs in other bac-
teria [16,41,42]. We have also characterized the protein-
interactions occurring between FliI, FliF and FlhA,
demonstrating a direct interaction of FliI and FlhA, and
FlhA and FliF. As well as interactions between the fla-
gellar proteins, we have also characterized four novel
interactions between the flagellar and T3S components.
The role of these interactions in the chlamydial replica-
tion cycle is discussed.
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Sequence analysis of FliI, FlhA and FliF
FliI (Cpn0858) is 434 amino acids in length with a pre-
dicted molecular mass of 47.5 kDa and a pI of 8.00. FliI
has significant sequence similarity with the b subunit of
the F0F1-ATPase and both its type III secretion paralog,
CdsN, and other flagellar ATPases, although the
sequence similarity is most striking in the ATPase
domain [43]. FliI has a non-conserved N-terminal region
(amino acids 1-150) which may be important for med-
iating protein-protein interactions, a catalytic domain
(amino acids 150-329), containing a conserved P loop,
Walker A and B domains, and a C-terminal non-con-
served domain (amino acids 329-434) of unknown func-
tion. FliI has a 34 percent sequence similarity to CdsN,
the C. pneumoniae T3S ATPase, and 36 percent similar-
ity with FliI from Salmonella. The active domain of FliI
has the most similarity to its paralogs and orthologs,
while the N- and C-terminal regions have the lowest
amount of similarity (Figure 1).
FlhA (Cpn0363) is 583 amino acids in length with a
predicted molecular mass of 65.6 kDa and a pI of 5.60.
The FlhA paralog in C. pneumoniae is the T3S protein
CdsV. FlhA has seven predicted transmembrane regions
in the N-terminal half of the protein (FlhA1-308), while
the C-terminal half of the protein is predicted to be
cytoplasmic (TMpred). FlhA from C. pneumoniae has
21 percent sequence orthology with FlhA from
Salmonella.
FliF (Cpn0860) is 342 amino acids in length with a
predicted molecular mass of 38.2 kDa and a pI of 9.5.
The FliF paralog in C. pneumoniae is the T3S protein
CdsJ. FliF has two predicted TM regions, one located
near the N-terminus and one located near the C-termi-
nus. FliF from C. pneumoniae is only 15 percent similar
to FliF from Salmonella.
Expression and ATPase activity of FliI
FliI has significant similarity with many characterized
ATPases, and this led us to explore the ATPase activity
Figure 1 Sequence conservation of FliI from C. pneumoniae with C. trachomatis and Salmonella. Sequence alignment (ClustalW) of the full
length FliI protein from C. pneumoniae, C. trachomatis, and Salmonella. Asterisk refers to identical amino acids, a double dot refers to a conserved
substitution and a single dot refers to a semi-conserved substitution. Outlined is the conserved P loop region in the Walker A domain.
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its ability to hydrolyze ATP using the malachite green
binding assay. Figure 2A shows that GST-FliI was essen-
tially free of contaminating proteins by SDS-PAGE and
anti-GST Western blot (left) or Coomassie blue stain
(right). GST-FliI hydrolyzed ATP in a dose- and time-
dependant manner at a rate of 0.15 ± .02 μmol min
-1
mg
-1 (Figure 2B i and ii, diamonds). This level of activity
is comparable to other flagellar ATPases as well as the
T3S paralog, CdsN [16,41,42]. ATPase activity of GST-
FliI peaked at 37°C, and at a pH of 8.0 (Figure 2 iii and
iv). Another GST-tagged protein, GST-CopN, purified
in the same manner as GST-FliI had negligible ATPase
activity (Figure 2B i and ii, squares).
FlhA interacts with FliF
FlhA is known to interact with the MS ring protein,
FliF, in other flagellar systems [33,34]. We explored the
interactions of these two proteins in C. pneumoniae.
Two fragments of FliF were cloned and expressed as
His-tagged proteins. His-FliF1-271 lacked the distal C-
terminal 70 amino acids while His-FliF35-341 lacked the
N-terminal 35 amino acids. Each fragment contained
only one of the two predicted TM regions. FliF1-271
migrated with an apparent molecular weight of 30 kDa,
while His-FliF35-341 migrated at 34 kDa. FlhA was
cloned and expressed as a soluble fragment with either
aG S To rH i st a g .F l h A 308-583 encoded the C-terminal
half of the protein, lacking the stretch of seven TM
domains. Expression and detection of His-FlhA308-583
Figure 2 Expression, purification, and optimal conditions for the time- and dose-dependant ATPase FliI. A: GST-FliI eluted off a
glutathione column (1 mL aliquots) and electrophoresed on an 11% SDS-PAGE gel and either probed for by anti-GST Western blot (left) or
stained by Coomassie blue (right). GST-FliI migrated at approximately 73 kDa, its predicated molecular mass. Numbers refer to the eluted
fraction. B: i) Time course of purified GST-FliI ATP hydrolysis (diamonds) and GST-CopN ATP hydrolysis as a negative control (squares). ii)
Inorganic phosphate released at different concentrations of GST-FliI (diamonds) and GST-CopN as a negative control (squares) iii) GST-FliI ATPase
activity at either 4°C, 16°C, 23°C, 37°C or 42°C. iv) GST-FliI ATPase activity at varying pH.
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migrated at the expected molecular weight of 30 kDa.
We used the bacterial-2-hybrid assay to test for interac-
tions between FliF and FlhA. Full length FlhA interacted
significantly with full length FliF, with a b-galactosidase
activity of 847.2 ± 21.2 units of activity, as compared
with a negative control value of 412.0 ± 82.4 units of
activity (Table 1). We next used GST pull-downs to
confirm the interactions found by the bacterial-2-hybrid
system and to determine the exact regions of the pro-
teins mediating these interactions (Figure 3A). All pro-
tein complexes were washed with either low or high salt
buffers containing 0.1% Triton X-100 to dissociate spur-
ious protein-protein interactions. GST-FlhA308-583 co-
purified with His-FliF35-341 but not His-FliF1-271,s u g -
gesting that the C-terminus of FliF (amino acids 271-
341) is required for interactions with the cytoplasmic
portion of FlhA.
FliI interacts with FlhA
In orthologous systems, it has been shown that FlhA
interacts with several soluble
components of the flagellar machinery, including the
ATPase, FliI [34]. Therefore, we investigated the possibi-
lity of whether FlhA interacts with FliI in C. pneumo-
niae. The bacterial-2-hybrid system was initially used to
screen for potential protein interactions. FlhA interacted
with FliI, with b-galactosidase activity of 942.9 ± 123.1
units of activity as compared to the negative control
with a value of 412.0 ± 82.4 units of activity (Table 1).
To confirm these protein-protein interactions we used
GST pull-down assays (Figure 3B). Initially FliI was
cloned as three constructs, full length FliI, a C-terminal
truncation of FliI (FliI1-400) and a N-terminal truncation
of FliI (FliI150-471). These three constructs were tested
for interaction with the His-FlhA308-583 construct. Full
length GST-FliI co-purified with His-FlhA308-583,s u g -
gesting that the cytoplasmic fragment of FlhA contains
the interactive domain. To determine the region of FliI
that interacts with FlhA, we reacted the two truncation
constructs of FliI with the cytoplasmic domain of FlhA.
Only FliI1-400 was able to co-purify with FlhA, and not
FliI150-471, suggesting that the FlhA binding domain
resides in the N-terminal 150 amino acids of FliI (Figure
3B). We next wanted to know if FliI interacts with FliF.
We therefore reacted GST-FliI against the two FliF con-
structs and found that there was no co-purification, sug-
gesting that any interaction between FliI and FliF, if
there is an association, would seem to be indirect and
mediated through the action of FlhA or other intermedi-
ate proteins (Figure 3C).
Cpn0859 interacts with FliI and FlhA
Cpn0859 is a predicted 179 amino acid protein with a PI
of 6.10 and a molecular mass of 20.3 kDa. The Cpn0859
ORF is encoded directly upstream of fliF and down-
stream of fliI, the flagellar ATPase. Based on its location
relative to FliI and FliF, we hypothesized that it may
interact with other flagellar components. We used GST
pull-down assays to explore this possibility. Initial GST
pull-downs indicated that full length His-Cpn0859 inter-
acts with GST-Cpn0859, suggesting the presence of a
Table 1 Interaction between the flagellar proteins of C. pneumoniae using the Bacterial-2-hybrid System
Plasmids b-Galactosidase Activity in units/mg bacteria Protein Functions
Negative Control
pT18 + pT25 412.0 ± 82.4 pT18: Empty vector
Positive Control: pT25: Empty vector
pT18-PknD + pT25-CdsD-FHA-2 996.3 ± 50.0 FliI: Putative flagellar ATPase
Negative Interactions: FliF: Putative flagellar MS ring protein
pT18-FliI + pT25-FliF 396.4 ± 32.1 FlhA: Putative flagellar integral membrane
pT18-FliF + pT25-Cpn0859 421.1 ± 25.9 protein
pT18-FliI + pT25-Cpn0706 404.4 ± 19.5 Cpn0859: Hypothetical C. pneumoniae
pT18-Cpn0706 + pT25-FlhA 443.0 ± 32.3 protein
Positive Interactions: Cpn0706: Putative T3S chaperone
pT18-FliF + pT25-FlhA 847.2 ± 21.2 CdsL: Putative T3S ATPase tethering
pT18-FliI + pT25-FlhA 942.9 ± 123.1 protein
pT18-FliI + pT25-CdsL 874.3 ± 59.3 CopN: Putative T3S plug protein
pT18-FliI + pT25-CopN 943.2 ± 74.2 Cpn0322: Putative CdsU ortholog
pT18-Cpn0322 + pT25-FlhA 779.9 ± 32.7
pT18-CdsL + pT25-FlhA 832.1 ± 23.3
* FliI, FliF, FlhA, CdsL, CopN, Cpn0706 and Cpn0322 were cloned into both the pT18 and pT25 vectors. The bacterial-2-hybrid was performed in triplicatea s
described in the Materials and Methods section. Empty pT18 and pT25 vectors were used as a negative control while pT18-PknD + pT25-CdsD-FHA-2 was used
as a positive control. The cut off for a positive interaction (577 units of activity/mg protein), is the mean of the negative control values (empty pT18 + pT25) plus
two standard deviations obtained from 20 assays.
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vation we treated Cpn0859 with formaldehyde prior to
PAGE and observed the presence of a monomer and a
dimer, migrating with apparent molecular weights of 22
kDa and 45 kDa (Figure 4B). We next explored the pos-
sible interaction of Cpn0859 with other flagellar proteins
in C. pneumoniae. Using GST pull-downs, His-Cpn0859
co-purified with the full length GST-FliI protein as well
as the GST-FliI1-400 protein, but not GST-FliI150-471
(Figure 4C). This suggests that Cpn0859 binds to the N-
terminus of FliI. GST pull-down assays showed an inter-
action between Cpn0859 and the FlhA308-583 protein,
the cytoplasmic domain of FlhA (Figure 4D). Cpn0859
did not co-purify with either FliF35-341 or FliF1-271 (Fig-
ure 4D), suggesting that Cpn0859 does not interact with
FliF.
FliI and FlhA interact with T3S components
Since Chlamydia have no apparent flagella, we investi-
gated whether the flagellar proteins FliI, FlhA and FliF
interact with T3S components. Using bacterial-2-hybrid
screening we found that FliI and FlhA interacted with
CdsL, the putative T3S ATPase regulator and tethering
protein, with a b-galactosidase activity of 874.3 ± 59.3
and 832 ± 23.3 units of activity, respectively. FliI also
interacted with CopN, the putative T3S plug protein,
with a b-galactosidase activity of 943.2 ± 74.2 units of
activity. We also found that FlhA interacted with the
putative YscU ortholog, CdsU, with a b-galactosidase
activity of 779.9 ± 32.7 units of activity, as well as CdsL,
with a b-galactosidase activity of 832.1 ± 23.3 units of
activity (Table 1). To corroborate these findings we uti-
l i z e dG S Tp u l l - d o w na s s a y sa n ds h o w e dt h a tG S T - F l i I
interacted with CdsL and CopN, but not Cpn0706 (Fig-
ure 5A), and GST-FlhA co-purified with both CdsL and
CdsU (Figure 5B). Control GST coated beads did not
co-purify with CdsL, CopN or CdsU.
Discussion
Sequencing of several Chlamydial genomes revealed a
conserved set of flagellar orthologs, despite the fact that
C. pneumoniae lack a flagellum and are considered non-
Figure 3 Interaction between the flagellar components using GST pull-down assays. A: GST- FlhA308-583 was bound to glutathione beads
and was used to pull down either His-FliF35-341 or His-FliF1-271 from an E. coli lysate. Beads were harvested by centrifugation and washed with
either 0 mM, 200 mM or 500 mM NaCl and probed for His-tagged protein by Western blot using anti-his antibody. GST- FlhA308-583 co-purified
with His-FliF35-341 but not His-FliF1-271 while GST alone did not co-purify with either. GST-FlhA308-583 is shown as a loading control. B: Full length
GST-FliI, GST-FliI1-400, or GST-FliI150-470 were bound to glutathione beads and were used to pull down His-FlhA308-583 from an E. coli lysate. Full
length GST-FliI and GST-FliI1-400 were able to co-purify with FlhA308-583 while GST-FliI150-470 was not. GST alone was not able to co-purify with His-
FlhA305-583. C: Full length GST-FliI was bound to glutathione beads and used to pull down His-FliF35-341 and His-FliF1-271. GST-FliI did not co-purify
with either FliF fragment.
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terization of three annotated flagellar proteins of C.
pneumoniae, FliI, FlhA and FliF, demonstrating ATPase
activity of FliI and interactions between these flagellar
orthologs. We have demonstrated that FliI hydrolyzes
ATP in a linear, time-and dose-dependant manner, with
optimal activity at a pH of 8.0 and a temperature of 37°
C. FliI also interacts with the cytoplasmic domain of
FlhA, while FlhA interacts with the C-terminal region of
the FliF protein. No direct interaction of FliI and FliF
was detected. Also, we have characterized an interaction
of both FlhA and FliI with Cpn0859, a fourth unanno-
tated protein. We also show that FliI interacts with
CdsL and CopN, two T3S components, while FlhA
interacts with CdsL and a third T3S component, CdsU.
Collectively, this data suggests that the flagellar proteins
of C. pneumoniae interact in a specific way with T3S
proteins and may play an important, as yet unidentified
role in the chlamydial replication cycle.
FliI hydrolyzes ATP in a linear, time- and dose-depen-
dant manner at a rate of 0.15 ± .02 μmol min
-1 mg
-1.
This rate is typical of other secretion ATPases such as
CdsN, EscN, or FliI from other bacterial species
[16,41,42]. The optimal pH for FliI ATPase activity is
8.0, which is the same as that for other flagellar
ATPases [42]. Extreme low or high pH greatly reduced
the activity, possibly due to protein denaturation. Also,
the enzyme activity peaked at a temperature of 37°C
and declined substantially beyond that. Although the
formation of higher-order complexes was not explored
here, other flagellar ATPases are thought to form a hex-
americ complex [44].
Figure 4 Interaction of His-CPn0859 and GST-Cpn0859, and dimerization of His-Cpn0859. A: Full length GST-Cpn0859 was bound to
glutathione beads and was used to pull down full length His-Cpn0859 from an E. coli lysate, as seen in Figure 3. GST-Cpn0859 co-purified with
His-Cpn0859. GST alone did no co-purify with His-Cpn0859, and GST-Cpn0859 is shown as a loading control. B: Full length His-Cpn0859 was
fixed with formaldehyde for 10 minutes prior to being electrophoresed on an 11% PAGE gel and probed for by anti-His Western blot. Cpn0859
monomers can be seen migrating at approximately 22 kDa while the formation of a dimer can be seen migrating at approximately 44 kDa. C:
Full length GST-FliI, GST-FliI1-400, or GST-FliI150-470 were bound to glutathione beads and were used to pull down His-Cpn0859 from an E. coli
lysate. They were washed in the same manner as above, and only full length GST-FliI and GST-FliI1-400 were able to co-purify with His-Cpn0859.
D: Full length GST-Cpn0859 was bound to glutathione beads and was used to pull down either His-FlhA308-583, His-FliF35-341 or His-FliF1-271 from
an E. coli lysate. GST-Cpn0859 co-purified with His- FlhA308-583, but not His-FliF35-341 or His-FliF1-271 while GST alone did no co-purify with either.
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intriguing since chlamydiae are thought to be non-
motile and not to possess flagella. FliF, FlhA and FliI
alone do not contain all the necessary components for a
functional flagella or secretion apparatus, however, a
rudimentary basal body or pore complex could be
formed by these three components. It is known that the
most rudimentary flagellar structure that can be
assembled is the MS ring, which consists of only the
FliF protein [29]. We have shown that these proteins
interact with one another (FliI, FlhA and FliF), most
likely at the inner membrane of C. pneumoniae.T h e
interaction between FliI and FlhA is mediated by the N-
terminal 150 amino acids of FliI and appears to be spe-
cific since it is not disrupted by high salt (500 mM).
Only the cytoplasmic domain of FlhA (amino acids 308-
583) was utilized in the GST pull-down, suggesting that
any protein interactions that occur are within this
region. Protein interaction studies with the full length
FlhA protein are difficult due to the presence of seven
transmembrane domains rendering full length FlhA
insoluble and making this portion of the protein unable
to bind to soluble flagellar components. Since FlhA is
known to interact with soluble components of the fla-
gellar apparatus in other bacteria, it is expected that the
cytoplasmic domain mediates an interaction with FliI
[25]. FliF is known to form the MS ring in flagellated
bacteria, and is one of the first components of the fla-
gellar basal body to be incorporated into the membrane
[26,29]. We detected an interaction of the C-terminal 70
amino acids of FliF with the cytoplasmic domain of
FlhA. These interactions were also stable in 500 mM
NaCl, suggesting that the interaction is specific. We did
not, however, detect any interaction between FliI and
FliF, suggesting that any interaction between those two
components may be mediated through the action of
another protein, possibly FlhA
In C. pneumoniae, Cpn0859 is encoded directly down-
stream of the ATPase, which led us to explore any inter-
actions Cpn0859 may have with other flagellar proteins.
We initially found that Cpn0859 was able to interact with
itself using a GST pull-down assay, suggesting that it
could form dimers in solution. To confirm this observa-
tion we utilized formaldehyde fixation followed by PAGE
analysis to visualize the formation of dimers. Using this
method we saw that Cpn0859 migrated in two molecular
forms, with sizes corresponding to both monomers and
dimers. We then explored possible interactions between
Cpn0859 and the other flagellar proteins and detected
interactions of Cpn0859 with both FliI and FlhA, but not
FliF. Cpn0859 bound to the N-terminal 150 amino acids
of FliI and the cytoplasmic region of FlhA. The interac-
tion of Cpn0859 with the cytoplasmic domain of FlhA
was expected as FlhA is known to interact with soluble
components of other flagellar systems [34]. We consid-
ered the possibility that Cpn0859 may in fact be the FliH
ortholog in C. pneumoniae as Cpn0859 has minor
sequence orthology to other FliH proteins, but after
further investigation we found that Cpn0859 did not
appear to play a regulatory role with FliI (data not
shown). Figure 6 summarizes the interactions between
FliI, FlhA and FliF (Figure 6A) and interactions between
Cpn0859, FlhA and FliI (Figure 6B).
Bacterial type III secretion (T3S) and flagellar secre-
tion systems are structurally similar, and may have a
common ancestry [21]. Although C. pneumoniae does
not contain a full repertoire of flagellar genes, it does
encode a complete T3S system which most likely
Figure 5 Interaction of FliI and FlhA with T3S components. A: Full length GST-FliI was bound to glutathione beads and were used to pull
down His-CdsL, His-CopN and His-Cpn0706. GST-FliI co-purified with both His-CdsL and His-CopN, but not His-Cpn0706. GST alone was not able
to co-purify with any of the proteins. GST-FliI is shown as a loading control. B: GST-FlhA308-583 was bound to glutathione beads and used to pull
down His-CdsL and His-Cpn0322. GST-FlhA308-583 co-purified with both CdsL and Cpn0322. GST alone did not co-purify with either protein. GST-
FlhA308-583 is shown as a loading control. C:
Stone et al. BMC Microbiology 2010, 10:18
http://www.biomedcentral.com/1471-2180/10/18
Page 8 of 12consists of specific protein complexes located in the
inner membrane [16,20,23]. We have characterized an
interaction of FliI with CdsL, the T3S ATPase tethering
protein. The C. pneumoniae FliH ortholog has not yet
been identified, and in the absence of FliH, CdsL may
play a regulatory role for both FliI and CdsN. FliI also
interacts with the CopN, the T3S plug protein, suggest-
ing that FliI may be involved in either the secretion of
effector proteins or regulation of the T3S system. YscU
orthologs have a flagellar paralog, FlhB, and Cpn0322 is
believed to be the C. pneumoniae YscU ortholog
(CdsU). FlhB is known to interact with FlhA, but in C.
pneumoniae no FlhB ortholog has been annotated. We
found that FlhA interacts with CdsU, suggesting
integration of FlhA into the inner membrane, associat-
ing with T3S components.
Conclusions
Based on all of our observations, it is possible that the
flagellar proteins may interact with components of the
T3S injectisome, forming a hybrid structure, thereby
playing an ancillary or accessory role in secretion of
type III effectors across either the cytoplasmic or inclu-
sion membrane. Another possibility is that there are
other, as yet unannotated proteins that play a role in a
putative flagellar system in C. pneumoniae. For example,
along with the FliH/FliI complex that is formed in other
bacteria, another protein, FliJ, which is a general
Figure 6 Interacting regions between FliI and FlhA, FliF, and Cpn0859. A: FliF contains two transmembrane regions and interacts with the
cytosolic domain of FlhA by its extreme C-terminal end. FlhA contains seven transmembrane regions and interacts with the N-terminal region of
FliI by its cytoplasmic domain. FliI contains a Walker A and B domain and mediates protein interactions by its N-terminus. B: Cpn0859 appears to
dimerize, and interacts with the cytosolic domain of FlhA and the N-terminal 150 amino acids of FliI.
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[39,44]. FliJ has not been identified in C. pneumoniae.
In the absence of a genetic manipulation system for the
chlamydiae, direct evidence for the role of these flagellar
proteins remains elusive. The fact that FliI is enzymati-
cally active and forms complexes in vitro with other fla-
gellar proteins, all of which are present in all other
chlamydiae sps. studied to date, suggests that these pro-
teins play an important role in chlamydial replication or
survival. Further studies using heterologous systems and
genetic complementation could help to decipher the
exact role of these flagellar proteins in chlamydiae.
Methods
Expression Plasmids
C. pneumoniae CWL029 (VR1310:ATCC) (GenBank
accession # AE001363) was the strain used to isolate
genomic DNA for cloning and protein expression. Full
length fliI, Cpn0859, cdsL, copN, Cpn0322,a n df r a g -
ments of flhA, fliF,a n dfliI were amplified from
CWL029 using AttB-containing primers (Gateway; Invi-
trogen). The amplified products were cloned into
pDONR201 (Gateway; Invitrogen) to generate pENT vec-
tors. The pENT vectors were then used in LR reactions
(Gateway; Invitrogen) to produce pEX vectors contain-
ing the genes of interest. We used either pEX17 (N
terminal His tag) or pEX15 (N terminal GST tag) vectors
for our protein expression. All constructs were con-
firmed by sequencing at the Molecular Biology Facility
at McMaster University.
To identify protein interactions we utilized the bacter-
ial-2-hybrid system [39]. Genes of interest were cloned
into either pT18 or pT25 plasmids, each of which
expresses a different fragment of adenylate cyclase.
When these two plasmids are co-transformed, expres-
sing the protein of interest fused to the adenylate
cyclase fragment, any interaction between the two pro-
teins results in production of cAMP. Increases in cAMP
r e s u l t si na ni n c r e a s ei nt h eb-galactosidase gene that
can be monitored using b-galactosidase activity assays.
pT18 and pT25 were digested with KpnI (New England
Biolabs) as well as genes amplified from CWL029 (fliI,
flhA, fliF, cdsL, Cpn0322, copN)t h a th a daK p n Is i t e
designed into the primers. Ligation was performed over-
night at 16°C using T4 Ligase (Invitrogen) and the
resulting mixture was used to transform E. coli XL-1
cells and transformants were selected on 100 μg/μL
ampicillin and 34 μg/μL chloramphenicol (Luria Bertani)
LB plates. Plasmids were prepared using the GenElute
Plasmid Miniprep Kit (Sigma).
Protein Expression
All constructs were expressed in E. coli Rosetta pLysS.
Expression plasmids were used to transform E. coli Rosetta
pLysS and plated on LB plates containing 100 μg/mL
ampicillin. LB broth (750 mL), containing antibiotics, was
then inoculated with 12 mL of an overnight culture and
grown at 37°C until they reached an optical density (OD)
600 of approximately 0.8. Cultures were then cooled on ice
to 20°C and induced with 0.2 mM of isopropyl b-D galac-
tosidase (IPTG). Cultures were then incubated at 23°C for
2 hours and bacteria were harvested by centrifugation at
6500 × g for 10 minutes in a Sorvall RC-5B centrifuge and
washed with ice-cold phosphate buffered saline (PBS).
Bacteria containing His-tagged protein were resuspended
in Binding Buffer (50 mM potassium phosphate pH 7.2,
150 mM KCl, 1 mM MgCl2) while the bacteria containing
GST-tagged protein were resuspended in PBS and stored
at -20°C until further use.
Purification of Recombinant Proteins
E. coli pellets containing over-expressed proteins were
thawed on ice and sonicated using a Fischer Scientific
Sonic Dismembrator Model 100, followed by centrifuga-
tion at 20,000 × g for 40 minutes to remove insoluble
material. Supernatants containing His-tagged protein
were stored at 4°C for use in GST pull-down assays
while the GST-tagged protein supernatents were filtered
through 0.45 μm acrodisc filters (Pall Corporation) and
incubated overnight at 4°C with 300 μL of Glutathione-
agarose beads (Sigma). For GST pull-down assays, beads
were blocked overnight in Tris Buffered Saline with
0.1% Tween-20 and 4% BSA and stored at 4°C until use.
For ATPase activity measurements, glutathione beads
were washed on a column with PBS + 0.1% Tween until
the flow-through had an OD280 of less than 0.005. GST-
tagged protein was then eluted off the beads using 1.5
μg/μL reduced glutathione (Sigma) and dialyzed against
activity buffer (50 mM Tris-HCL pH 7.0, 5 mM MgCl2,
10 mM KCl). Purity was confirmed using SDS-PAGE
and Coomassie blue staining.
Dimerization Assay
In order to determine whether Cpn0859 formed dimers,
formaldehyde fixation and non-denaturing PAGE were
used. His-Cpn0859 was purified from Ni-NTA beads,
dialyzed against PBS and concentrated using Amicon 10
kDa (Millipore) concentrators to a final concentration of
1 μg/μl. Formaldehyde was added to purified His-
Cpn0859 to a final concentration of 10% and fixation
was allowed to continue for 10 minutes. Samples con-
taining 1 μg of Cpn0859 were electrophoresed on an 8%
non-denaturing PAGE and visualized by Western blot
using anti-His antibody (Sigma).
ATPase Activity
ATP hydrolysis by GST-FliI purified from glutathione-
agarose beads was measured using a malachite green
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activity was determined using the equation of a standard
line generated using phosphate standard (R & D Sys-
tems). Reaction mixtures contained 150 ng of GST-FliI,
4m MA T P ,5 0m MT r i s - H C Lp H7 . 0 ,5m MM g C l 2,
and 10 mM KCl. The reaction mixture (1 mL) was incu-
bated at 37°C for 1 hour and 50 μLo ft h em i x t u r ew a s
taken for inorganic phosphate determination at various
time points. The reaction was stopped by the addition
of 10 μL of Malachite Green Reagent A followed by 10
μL of Malachite Green Reagent B and incubated at
r o o mt e m p e r a t u r ef o ro n em i n u t eb e f o r ea nO D 610
reading was taken, according to the manufacturer’s
instructions. For the negative control, purified FliI was
digested for 10 minutes at 37°C using Proteinase K
(Invitrogen). Also, as a negative control, another GST-
tagged protein (CopN) known not to have ATPase activ-
ity was purified in the same manner and tested for
activity. ATPase activity was expressed as μmol phos-
phate released min
-1 mg
-1 of protein, and all experi-
ments were performed in triplicate.
GST Pull-down Assays
To examine the interaction of the flagellar proteins,
GST pull-down assays were performed as described pre-
viously with the following modifications [20]. Briefly,
glutathione agarose beads (30 μL) bound to fifty nano-
grams of GST tagged FliI, Cpn0859, or FlhA was used
in the assay. The beads were incubated overnight at 4°C
with the E. coli lysate expressing the His-tagged pro-
teins. The beads were collected by centrifugation and
washed with increasing concentrations of NaCl to elimi-
nate spurious protein interactions. All proteins were
eluted from the Glutathione beads and electrophoresed
on an 11% SDS-PAGE gel before being probed for His-
tagged protein. As a negative control, GST alone was
incubated on beads with the E. coli lysates.
Bacterial-2-Hybrid Assay
The bacterial-2-hybrid assay uses protein-protein inter-
actions to bring two fragments of adenylate cyclase cata-
lytic domain together to produce cAMP, stimulating b-
galactosidase activity. b-galactosidase activity is therefore
a representation of protein interaction. This protocol
was performed as described by Karimova et al, 2005
[45]. Briefly, E. coli DHP-1 cells (an adenylate cyclase
deficient cell line) were transformed using pT18-FliI/
pT18-FlhA/pT18-FliF and either pT25-FlhA or pT25-
FliF and selected with 100 μg/μL ampicillin and 34 μg/
μL chloramphenicol. Three individual colonies were
selected from each plate and grown overnight in 3.0 mL
of LB at 30°C in the presence of 0.5 mM IPTG plus
appropriate antibiotics. Overnight culture (200 μL) was
diluted 1 in 5 into M63 buffer (75 mM (NH4)2SO4,1 1 0
mM KH2PO4,2 0 0m MK 2HPO4,5m MF e S O 4-7H2O)
and the optical density at 600 nm was recorded. The
cells were permeabilized using 0.01% Toluene and 0.01%
SDS. For the reaction, 50 μL of the permeabilized cells
were diluted into 450 μL of LB broth. The diluted cells
were then added to 500 μLo fP M 2( 7 0m MN a 2HPO4-
H2O, 30 mM NaHPO4-H2O, 1 mM MgSO4,a n d0 . 2
mM MnSO4) buffer containing 100 mM b-mercap-
toethanol. The reaction was initiated by adding 250 μL
of 12 mg/mL ortho-nitrophenyl-b-galactoside and
allowed to continue for 15 seconds at 28°C. The reac-
tion was stopped by the addition of 500 μLo f1 . 0M
Na2CO3. The absorbance was measured at 420 nm and
the b-galactosidase activity was expressed as units of b-
galactosidase activity per milligram of bacteria. Empty
pT18 and pT25 vectors were transformed into E. coli
DHP1 cells as a negative control and pT18-CopN and
pT25-CdsN were used as a positive control (38). The
cutoff for a positive interaction (677 units activity/mg
bacteria) was determined as the mean plus two standard
deviations of the negative control values obtained from
20 assays.
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